BioSyent, Inc. (RX.V)
15.50
-0.20
(-1.27%)
CAD |
TSXV |
Aug 24, 16:00
BioSyent Net Income (Quarterly) : 2.849M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.849M |
| March 31, 2026 | 2.345M |
| December 31, 2025 | 1.992M |
| September 30, 2025 | 2.682M |
| June 30, 2025 | 2.018M |
| March 31, 2025 | 2.320M |
| December 31, 2024 | 1.613M |
| September 30, 2024 | 2.308M |
| June 30, 2024 | 1.580M |
| March 31, 2024 | 1.769M |
| December 31, 2023 | 1.451M |
| September 30, 2023 | 2.351M |
| June 30, 2023 | 1.483M |
| March 31, 2023 | 1.175M |
| December 31, 2022 | 1.200M |
| September 30, 2022 | 1.453M |
| June 30, 2022 | 1.218M |
| March 31, 2022 | 1.588M |
| December 31, 2021 | 1.878M |
| September 30, 2021 | 1.721M |
| June 30, 2021 | 1.018M |
| March 31, 2021 | 1.664M |
| December 31, 2020 | 0.6657M |
| September 30, 2020 | 0.9559M |
| June 30, 2020 | 0.7222M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.452M |
| December 31, 2019 | 1.168M |
| September 30, 2019 | 1.532M |
| June 30, 2019 | 0.6908M |
| March 31, 2019 | 0.9782M |
| December 31, 2018 | 1.671M |
| September 30, 2018 | 1.271M |
| June 30, 2018 | 1.620M |
| March 31, 2018 | 1.143M |
| December 31, 2017 | 1.457M |
| September 30, 2017 | 1.295M |
| June 30, 2017 | 1.553M |
| March 31, 2017 | 0.9016M |
| December 31, 2016 | 1.095M |
| September 30, 2016 | 1.247M |
| June 30, 2016 | 1.015M |
| March 31, 2016 | 0.9519M |
| December 31, 2015 | 0.7626M |
| September 30, 2015 | 1.188M |
| June 30, 2015 | 0.851M |
| March 31, 2015 | 0.9627M |
| December 31, 2014 | 0.7532M |
| September 30, 2014 | 1.001M |
| June 30, 2014 | 0.8888M |
| March 31, 2014 | 0.5114M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | -1.412M |
| Bausch Health Cos., Inc. | 359.94M |
| Cipher Pharmaceuticals, Inc. | 5.556M |
| Revive Therapeutics Ltd. | -0.5065M |
| Knight Therapeutics, Inc. | -3.361M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 19.87M |
| Total Expenses (Quarterly) | 17.02M |
| EPS Diluted (Quarterly) | 0.245 |
| Enterprise Value | 169.97M |
| Gross Profit Margin (Quarterly) | 65.02% |
| Profit Margin (Quarterly) | 14.34% |
| Earnings Yield | 5.53% |
| Operating Earnings Yield | 7.24% |
| Normalized Earnings Yield | 5.530 |